Stock-Based Compensation (Tables)

6 Months Ended

Jul. 30, 2016

Stock-based compensation expense by type of grant for each period presented was as follows (in thousands):



	Three Months Ended						Six Months Ended
	July 30, 2016			August 1, 2015			July 30, 2016			August 1, 2015
Stock appreciation rights ("SARs")	$	—		$	—		$	—		$	30
Non-vested stock	2,213			1,808			3,949			3,414
Performance shares	1,530			1,412			2,603			2,485
Total compensation expense	3,743			3,220			6,552			5,929
Related tax benefit	(1,408		)	(1,211		)	(2,464		)	(2,230		)
Stock-based compensation expense, net of tax	$	2,335		$	2,009		$	4,088		$	3,699

The following table summarizes SARs activity for the six months ended July 30, 2016:



SARs	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in thousands)
Outstanding, vested and exercisable at January 30, 2016	224,400		$	17.16
Forfeited	(34,000	)	14.18
Outstanding, vested and exercisable at July 30, 2016	190,400		$	17.70	1.3	$	—

The following table summarizes non-vested stock activity for the six months ended July 30, 2016:



Non-vested Stock	Number of Shares		Weighted Average Grant Date Fair Value
Outstanding at January 30, 2016	894,526		$	20.20
Granted	1,254,651		6.95
Vested	(362,756	)	19.44
Forfeited	(39,935	)	15.66
Outstanding at July 30, 2016	1,746,486		10.94

The following table summarizes information about the performance shares that were outstanding at July 30, 2016:



Period Granted	Target Shares Outstanding at January 30, 2016	Target Shares Granted	Target Shares Vested		Target Shares Forfeited		Target Shares Outstanding at July 30, 2016	Weighted Average Grant Date Fair Value Per Share
2014	160,423	—	(3,438	)	(2,292	)	154,693	$	33.84
2015	223,876	—	(6,983	)	(3,809	)	213,084	28.33
2016	—	451,680	(5,168	)	—		446,512	8.69
Total	384,299	451,680	(15,589	)	(6,101	)	814,289